Daratumumab, Bortezomib, Lenalidomide and Dexamethasone, Upfront Autologous Transplant and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Oren Pasvolsky, Muhammad Bilal Abid, Denái R. Milton, Mark R. Tanner, Qaiser Bashir, Samer A. Srour, Neeraj Y. Saini, Paul Lin, Jeremy Ramdial, Yago L. Nieto, Guilin Tang, Asad A. Haider
+10 more Yosra M. Aljawai, Partow Kebriaei, Mahmoud Gaballa, Krina K. Patel, Christine Ye, Sheeba K. Thomas, Robert Z. Orlowski, Richard E. Champlin, Elizabeth J. Shpall, Muzaffar H. Qazilbash
DOI: 10.1016/j.jtct.2025.12.636
Cited by: 0

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Chronic Lymphocytic Leukemia Research Bone health and treatments

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S442–S442
Publication date
1 February 2026
Language
EN